Clinical Trial: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06832618) titled 'A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis' on Feb. 04.

Brief Summary: The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to <18 Years Old) with moderate atopic dermatitis.

Study Start Date: May 28, 2025

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis

Intervention: DRUG: Ruxolitinib

The study cream will be applied topically as defined in the protocol for each period.

DRUG: Vehicle Cream

Matching vehicle cream will be applied topically as defined in the pr...